Tested Applications
| Positive WB detected in | HeLa cells, MCF-7 cells, HepG2 cells |
| Positive IP detected in | HepG2 cells |
| Positive IHC detected in | human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
15278-1-AP targets POLE3 in WB, IHC, IF/ICC, IP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag7396 Product name: Recombinant human POLE3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-147 aa of BC003166 Sequence: MAERPEDLNLPNAVITRIIKEALPDGVNISKEARSAISRAASVFVLYATSCANNFAMKGKRKTLNASDVLSAMEEMEFQRFVTPLKEALEAYRREQKGKKEASEQKKKDKDKKTDSEEQDKSRDEDNDEDEERLEEEEQNEEEEVDN Predict reactive species |
| Full Name | polymerase (DNA directed), epsilon 3 (p17 subunit) |
| Calculated Molecular Weight | 17 kDa |
| Observed Molecular Weight | 17 kDa |
| GenBank Accession Number | BC003166 |
| Gene Symbol | POLE3 |
| Gene ID (NCBI) | 54107 |
| RRID | AB_2166751 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9NRF9 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for POLE3 antibody 15278-1-AP | Download protocol |
| IHC protocol for POLE3 antibody 15278-1-AP | Download protocol |
| IP protocol for POLE3 antibody 15278-1-AP | Download protocol |
| WB protocol for POLE3 antibody 15278-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The POLE3 Polyclonal antibody (Cat# 15278-1-AP) has 4 total citations. These appear in Int J Biochem Cell Biol, Front Oncol, DNA Repair (Amst), and bioRxiv. The associated research fields include prostate cancer cell viability and EMT, oncogenesis in lung adenocarcinoma, and DNA replication mechanisms involving the nuclear structural protein NuMA.
| Species | Application | Title |
|---|---|---|
Int J Biochem Cell Biol SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis. | ||
DNA Repair (Amst) The nuclear structural protein NuMA is required for efficient DNA replication and supports the association of core replication factors to replication forks. | ||
bioRxiv The nuclear structural protein NuMA is required for efficient DNA replication by ensuring association of core replication factors to replication forks. |











